Search Results

Filter
  • 1-10 of  647 results for ""Angiotensin II Type 1 Receptor Blockers""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects.

  • Authors : Tehrani AY; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Room 217, Vancouver, BC, V6T 1Z3, Canada.

Subjects: Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/Angiotensin II Type 1 Receptor Blockers*/pharmacology ; Angiotensin Receptor Antagonists*; Angiotensin II/Angiotensin II/Angiotensin II/metabolism

  • Source: Scientific reports [Sci Rep] 2022 Jun 13; Vol. 12 (1), pp. 9771. Date of Electronic Publication: 2022 Jun 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker.

  • Authors : Arai K; End-Organ Disease Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan. .; Global Project Management Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan. .

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*drug therapy ; Imidazoles/Imidazoles/Imidazoles/*therapeutic use

  • Source: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2020 Nov; Vol. 43 (11), pp. 1204-1213. Date of Electronic Publication: 2020 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Angiotensin involvement in trauma processing-exploring candidate neurocognitive mechanisms of preventing post-traumatic stress symptoms.

  • Authors : Shkreli L; Department of Psychiatry, University of Cambridge, Cambridge, UK.; Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum, Bochum, Germany.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensins/Angiotensins/Angiotensins/*antagonists & inhibitors ; Cognition/Cognition/Cognition/*drug effects

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2020 Feb; Vol. 45 (3), pp. 507-514. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine.

  • Authors : Huo X; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100102, China.; Qiao L

Subjects: Drug Discovery* ; Medicine, Chinese Traditional*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology

  • Source: Scientific reports [Sci Rep] 2019 Nov 07; Vol. 9 (1), pp. 16205. Date of Electronic Publication: 2019 Nov 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Neprilysin Inhibitor-Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice.

  • Authors : Zhang H; Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China.; Liu G

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*pharmacology ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Inflammation/Inflammation/Inflammation/*prevention & control

  • Source: Scientific reports [Sci Rep] 2019 Apr 24; Vol. 9 (1), pp. 6509. Date of Electronic Publication: 2019 Apr 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization.

  • Authors : Jeon EJ; Department of Pharmacology, Gachon University School of Medicine, Incheon, 21999, Republic of Korea.; Kim DY

Subjects: Adipocytes, Brown/Adipocytes, Brown/Adipocytes, Brown/*drug effects ; Adipocytes, White/Adipocytes, White/Adipocytes, White/*drug effects ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology

  • Source: Scientific reports [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1236. Date of Electronic Publication: 2019 Feb 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats.

  • Authors : Komaki H; Department of Cardiology, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu, 501-1194, Japan.; Iwasa M

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects

  • Source: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2018 Nov; Vol. 41 (11), pp. 886-896. Date of Electronic Publication: 2018 Sep 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review.

  • Authors : Borém LMA; Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, Minas Gerais, Brazil.; Medicine Department, Faculdades Integradas Pitágoras, Montes Claros, Minas Gerais, Brazil.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Non-alcoholic Fatty Liver Disease/Non-alcoholic Fatty Liver Disease/Non-alcoholic Fatty Liver Disease/*drug therapy ; Renin-Angiotensin System/Renin-Angiotensin System/Renin-Angiotensin System/*drug effects

  • Source: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2018 Jun; Vol. 41 (6), pp. 394-405. Date of Electronic Publication: 2018 Apr 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.

  • Authors : Imaizumi S; Department of Cardiology, Fukuoka University School of Medicine, Japan.; Miura S

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology ; Collateral Circulation/Collateral Circulation/Collateral Circulation/*drug effects

  • Source: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2006 Mar; Vol. 29 (3), pp. 135-41.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Losartan improves intestinal mucositis induced by 5-fluorouracil in mice.

  • Authors : Oliveira MMB; Post Graduate Program Biotechnology-RENORBIO, Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil.; de Araújo AA

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*adverse effects ; Fluorouracil/Fluorouracil/Fluorouracil/*adverse effects

  • Source: Scientific reports [Sci Rep] 2021 Dec 01; Vol. 11 (1), pp. 23241. Date of Electronic Publication: 2021 Dec 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
  • 1-10 of  647 results for ""Angiotensin II Type 1 Receptor Blockers""